News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eisai Company, Ltd. (ESALY.PK) Signs License Agreement with Biocompatibles International PLC (BII.L) for Drug-Eluting Bead Products for Embolisation



8/4/2009 9:51:52 AM

Tokyo, July 28, 2009 (JCN Newswire) - Eisai Co., Ltd. announced today that the Company has concluded a license agreement with Biocompatibles International plc (Headquarters: Farnham, United Kingdom, CEO: Simon Crispin, "Biocompatibles") for the development and commercialisation of Drug-Eluting Bead Products for embolisation in Japan.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES